Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueTax ProvisionsTax Rate
Others
Ratios

Metlife (MET-PF) EBT (2016 - 2025)

Historic EBT for Metlife (MET-PF) over the last 17 years, with Q3 2025 value amounting to $1.2 billion.

  • Metlife's EBT fell 3931.8% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.9 billion, marking a year-over-year decrease of 495.95%. This contributed to the annual value of $5.6 billion for FY2024, which is 16003.7% up from last year.
  • According to the latest figures from Q3 2025, Metlife's EBT is $1.2 billion, which was down 3931.8% from $980.0 million recorded in Q2 2025.
  • In the past 5 years, Metlife's EBT registered a high of $4.5 billion during Q2 2021, and its lowest value of $257.0 million during Q1 2023.
  • Over the past 5 years, Metlife's median EBT value was $1.2 billion (recorded in 2025), while the average stood at $1.4 billion.
  • Over the last 5 years, Metlife's EBT had its largest YoY gain of 217766.5% in 2021, and its largest YoY loss of 9484.32% in 2021.
  • Quarter analysis of 5 years shows Metlife's EBT stood at $1.7 billion in 2021, then rose by 19.32% to $2.0 billion in 2022, then plummeted by 53.55% to $941.0 million in 2023, then surged by 46.76% to $1.4 billion in 2024, then decreased by 12.38% to $1.2 billion in 2025.
  • Its EBT stands at $1.2 billion for Q3 2025, versus $980.0 million for Q2 2025 and $1.4 billion for Q1 2025.